<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-05-30T14:12:03Z</responseDate><request verb="GetRecord" identifier="oai:riubu.ubu.es:10259/6825" metadataPrefix="mods">https://riubu.ubu.es/oai/request</request><GetRecord><record><header><identifier>oai:riubu.ubu.es:10259/6825</identifier><datestamp>2026-02-06T12:50:50Z</datestamp><setSpec>com_10259_4363</setSpec><setSpec>com_10259_5086</setSpec><setSpec>com_10259_2604</setSpec><setSpec>com_10259_4365</setSpec><setSpec>col_10259_4364</setSpec><setSpec>col_10259_4366</setSpec></header><metadata><mods:mods xmlns:mods="http://www.loc.gov/mods/v3" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
<mods:name>
<mods:namePart>Rubio Antolin, Ana Rosa</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>González, Rocío</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Busto Vázquez, Natalia</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Vaquero Gutiérrez, Mónica</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Iglesias, Ana L.</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Jalón Sotés, Félix Ángel</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Espino Ordóñez, Gustavo</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Rodríguez, Ana M.</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>García Ruiz, Begoña</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Manzano, Blanca R. .</mods:namePart>
</mods:name>
<mods:extension>
<mods:dateAvailable encoding="iso8601">2022-09-01T08:24:11Z</mods:dateAvailable>
</mods:extension>
<mods:extension>
<mods:dateAccessioned encoding="iso8601">2022-09-01T08:24:11Z</mods:dateAccessioned>
</mods:extension>
<mods:originInfo>
<mods:dateIssued encoding="iso8601">2021-09</mods:dateIssued>
</mods:originInfo>
<mods:identifier type="issn">1999-4923</mods:identifier>
<mods:identifier type="uri">http://hdl.handle.net/10259/6825</mods:identifier>
<mods:identifier type="doi">10.3390/pharmaceutics13101540</mods:identifier>
<mods:identifier type="essn">1999-4923</mods:identifier>
<mods:abstract>An important challenge in the field of anticancer chemotherapy is the search for new species&#xd;
to overcome the resistance of standard drugs. An interesting approach is to link bioactive ligands to&#xd;
metal fragments. In this work, we have synthesized a set of p-cymene-Ru or cyclopentadienyl-M&#xd;
(M = Rh, Ir) complexes with four chrysin-derived pro-ligands with different -OR substituents at&#xd;
position 7 of ring A. The introduction of a piperidine ring on chrysin led to the highly cytotoxic&#xd;
pro-ligand HL4 and its metal complexes L4-M (SW480 and A549 cell lines, cytotoxic order: L4-Ir >&#xd;
L4-Ru ≈ L4-Rh). HL4 and its complexes induce apoptosis and can overcome cis-platinum resistance.&#xd;
However, HL4 turns out to be more cytotoxic in healthy than in tumor cells in contrast to its metal&#xd;
complexes which displayed higher selectivity than cisplatin towards cancer cells. All L4-M complexes&#xd;
interact with double stranded DNA. Nonetheless, the influence of the metal is clear because only&#xd;
complex L4-Ir causes DNA cleavage, through the generation of highly reactive oxygen species (1O2&#xd;
).&#xd;
This result supports the hypothesis of a potential dual mechanism consisting of two different chemical&#xd;
pathways: DNA binding and ROS generation. This behavior provides this complex with a great&#xd;
effectivity in terms of cytotoxicity</mods:abstract>
<mods:language>
<mods:languageTerm>eng</mods:languageTerm>
</mods:language>
<mods:accessCondition type="useAndReproduction">http://creativecommons.org/licenses/by/4.0/</mods:accessCondition>
<mods:accessCondition type="useAndReproduction">info:eu-repo/semantics/openAccess</mods:accessCondition>
<mods:accessCondition type="useAndReproduction">Atribución 4.0 Internacional</mods:accessCondition>
<mods:subject>
<mods:topic>Chrysin ligands</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Iridium</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Ruthenium</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Rhodium</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Cancer</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Metallodrugs</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Piperidine</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Half-sandwich</mods:topic>
</mods:subject>
<mods:titleInfo>
<mods:title>Anticancer Activity of Half-Sandwich Ru, Rh and Ir Complexes with Chrysin Derived Ligands: Strong Effect of the Side Chain in the Ligand and Influence of the Metal</mods:title>
</mods:titleInfo>
<mods:genre>info:eu-repo/semantics/article</mods:genre>
</mods:mods></metadata></record></GetRecord></OAI-PMH>